Biologics Reshape Treatment of Eosinophilic Esophagitis in Children
Monoclonal antibody therapy, led by dupilumab, is transforming the treatment of eosinophilic esophagitis in children after decades of limited options.
Monoclonal antibody therapy, led by dupilumab, is transforming the treatment of eosinophilic esophagitis in children after decades of limited options.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine